• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放化疗与食管癌切除术的最佳间隔时间是多久?

What is the optimal interval between chemoradiation and esophagectomy?

机构信息

Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland 21014, USA.

出版信息

Semin Thorac Cardiovasc Surg. 2012 Summer;24(2):87-9. doi: 10.1053/j.semtcvs.2012.06.001.

DOI:10.1053/j.semtcvs.2012.06.001
PMID:22920522
Abstract

Locally advanced esophageal cancer requires multimodality therapy-most commonly induction chemoradiation followed by esophagectomy. There is a paucity of literature on the optimal time interval between induction treatment and resection. Patient readiness and healthy tissue, as well as tumor responses to radiation, are factors to consider. Two recent retrospective large-center studies on this topic are reviewed.

摘要

局部晚期食管癌需要多模式治疗——最常见的是诱导放化疗后行食管切除术。关于诱导治疗与切除之间的最佳时间间隔,文献报道较少。患者的准备情况和健康组织,以及肿瘤对放疗的反应,都是需要考虑的因素。本文回顾了两项关于该主题的近期大型中心回顾性研究。

相似文献

1
What is the optimal interval between chemoradiation and esophagectomy?放化疗与食管癌切除术的最佳间隔时间是多久?
Semin Thorac Cardiovasc Surg. 2012 Summer;24(2):87-9. doi: 10.1053/j.semtcvs.2012.06.001.
2
Esophagectomy after chemoradiation: who and when to operate.放化疗后食管癌切除术:谁和何时手术。
Semin Thorac Cardiovasc Surg. 2012 Winter;24(4):288-93. doi: 10.1053/j.semtcvs.2012.10.005.
3
Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.临床 T2N0 期食管癌直接手术与诱导放化疗的疗效比较:决策分析。
J Thorac Cardiovasc Surg. 2018 May;155(5):2221-2230.e1. doi: 10.1016/j.jtcvs.2018.01.006. Epub 2018 Jan 12.
4
Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?新辅助放化疗反应者、无反应者以及接受局部晚期食管鳞状细胞癌原发切除术患者的生存比较:新辅助放化疗对所有患者都有益吗?
Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):460-6. doi: 10.1093/icvts/ivt216. Epub 2013 May 31.
5
The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.三孔微创食管切除术:新辅助化疗和放疗后的安全术式
Semin Thorac Cardiovasc Surg. 2015 Summer;27(2):205-15. doi: 10.1053/j.semtcvs.2015.06.003. Epub 2015 Jun 20.
6
Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival.诱导化疗后病理淋巴结阳性食管癌患者辅助化疗与生存改善相关。
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1725-1735. doi: 10.1016/j.jtcvs.2018.05.100. Epub 2018 Jun 28.
7
Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy.对新辅助治疗完全缓解的食管腺癌疾病复发和生存的预测因素
Am J Surg Pathol. 2015 Aug;39(8):1085-92. doi: 10.1097/PAS.0000000000000420.
8
Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.食管癌新辅助化疗的当前概念与未来潜力
Expert Rev Gastroenterol Hepatol. 2016;10(3):383-92. doi: 10.1586/17474124.2016.1116936. Epub 2015 Dec 2.
9
Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.食管癌同步放化疗后联合免疫治疗行食管癌切除术的安全性和可行性。
J Thorac Cardiovasc Surg. 2021 Mar;161(3):836-843.e1. doi: 10.1016/j.jtcvs.2020.11.106. Epub 2020 Dec 17.
10
Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.放化疗后延迟与及时行食管癌切除术治疗食管腺癌的结果。
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2555-2566. doi: 10.1016/j.jtcvs.2019.09.169. Epub 2019 Oct 22.

引用本文的文献

1
Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.新辅助放化疗与手术时间间隔与食管和胃食管交界处癌完全组织学肿瘤反应的关系:一项全国性队列研究。
Dis Esophagus. 2020 May 15;33(5). doi: 10.1093/dote/doz078.
2
[Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].[食管癌多模式治疗中食管切除术的时机:新辅助治疗与手术之间的时间间隔对结局和反应的影响]
Chirurg. 2015 Sep;86(9):874-80. doi: 10.1007/s00104-014-2916-6.